Full-Time

Sales Specialist

Training

BioPhorum

BioPhorum

51-200 employees

Membership-based forums for biopharma and devices

No salary listed

London, UK

Remote

UK home-based role with customer meetings, training activity, BioPhorum events, and occasional international travel.

Category
Sales & Account Management (1)
Required Skills
Sales
Forecasting
CRM

Get referred to BioPhorum

See people who can refer or advise you

Requirements
  • Approximately 3–5 years of experience in quota-bearing business-to-business sales, business development, or new business sales.
  • Experience selling training, consulting, compliance, auditing, professional services, software as a service, data, or another solution-led business-to-business proposition is preferred, ideally within pharmaceuticals, life sciences, or another regulated environment.
  • Ability to sell complex business-to-business solutions, build credibility quickly, and create customer value.
  • Ability to create opportunities through prospecting, conduct discovery conversations, build relationships, sell to multiple stakeholders, navigate complex buying processes, present solutions, articulate commercial value, manage pipelines, use customer relationship management systems, and forecast.
Responsibilities
  • Drive new business across the training services portfolio, including training packages, tailored training solutions, Compliance Hub consulting and auditing services, cross-selling opportunities, and solutions addressing customer capability, compliance, and operational needs.
  • Identify and engage new-logo prospects across target organisations.
  • Build and manage a high-quality sales pipeline.
  • Run structured discovery conversations with customers.
  • Develop proposals, pitches, and commercial recommendations.
  • Manage opportunities through the sales cycle and close new business.
  • Identify cross-sell opportunities within existing accounts.
  • Develop opportunities for Compliance Hub consulting and auditing services.
  • Work with Marketing to convert campaigns and targeted outreach into opportunities.
  • Maintain customer relationship management discipline, forecasting, and opportunity management.
  • Build relationships with senior stakeholders across training, quality, compliance, operations, regulatory, and commercial functions.
  • Travel to customer meetings, training activity, BioPhorum events, and occasionally internationally.
Desired Qualifications
  • Experience selling training, consulting, compliance, auditing, professional services, software as a service, or data solutions.
  • Experience in pharmaceuticals, life sciences, or another regulated environment.

BioPhorum is a B2B membership organization that enables collaboration across global biopharmaceutical and medical device industries. It provides a non-competitive space where leaders and experts tackle shared challenges, define best practices, and advance projects through focused forums called Phorums. Members from license holders, manufacturers, CDMOs, and suppliers work on industry-wide initiatives to improve operations, reduce costs, and streamline regulatory processes, plus tools like the Digital Plant Maturity Model (DPMM) to guide digital transformation. Its goal is to accelerate progress in biopharma and medical device manufacturing by sharing knowledge, setting industry-wide practices, and improving efficiency and regulatory readiness.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2008

Get referred to BioPhorum

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BioPhorum deepened monetization with subscription HCP data and flexible pricing in June 2026.
  • Regulators MHRA, British Pharmacopoeia, and USP joined its July 2026 small-molecule initiative.
  • PharmaX acquisition converts BioPhorum insights into implementation services for manufacturers.

What critics are saying

  • Recent acquisitions of PharmaX, Inspired Pharma, and Compliance Hub complicate integration.
  • Training and consulting expansion dilutes the pure-membership model by 2026.
  • Pharma giants can internalize collaboration forums, shrinking BioPhorum’s relevance by 2028.

What makes BioPhorum unique

  • BioPhorum convened 20 organizations on synthetic molecules in July 2026.
  • Its 2026 advisory board includes Pfizer, GSK, Eli Lilly, and Merck.
  • BioPhorum’s HCP platform offers 300 risk-assessed proteins with API integration.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
PR Newswire
May 7th, 2026
BioPhorum Acquires PharmaX Solutions, Empowering The Life Sciences Industry to Turn Best Practice Insight into Operational Solutions at Scale

/PRNewswire/ -- BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions...

PR Newswire
Feb 5th, 2026
BioPhorum forms Strategic Advisory Board with 14 pharma executives to accelerate industry collaboration

BioPhorum, a pharmaceutical industry collaborative network, has announced the formation of its inaugural Strategic Advisory Board comprising 14 senior executives from major pharmaceutical companies. The board will provide executive guidance on critical industry challenges including global regulation, new technology and supply chain resilience. Members include executives from Pfizer, GSK, Eli Lilly, Amgen, Sanofi, Merck, SK Pharmteco, Fujifilm BioTechnologies, eXmoor, Sartorius, UCB and Cytiva. The board will serve as a forum for strategic dialogue on pressing industry-wide challenges and opportunities. BioPhorum CEO Deborah Kobewka described the board's launch as "a defining milestone", noting that executive-led direction is crucial as the industry navigates volatility and a challenging global investment landscape. The board aims to help members turn market complexity into a shared roadmap for sustainable growth.

PharmiWeb
Dec 18th, 2025
BioPhorum acquires Inspired Pharma to enhance its training and support for pharmaceutical professionals worldwide

Media Release 17 December 2025 BioPhorum acquires Inspired Pharma to enhance its training and support for pharmaceutical professionals worldwide Strategic acquisition strengthens BioPhorum’s ability to deliver insight, expertise, and practical solutions to its global membership and life sciences client community across the pharmaceutical value chain BioPhorum is pleased to announce the acquisition of Inspired Pharma, a leading provider of specialist training for the...

PharmiWeb
May 20th, 2025
Biophorum Announces Appointment Of Dr. Uwe Buecheler To Board Of Directors

19 May 2025London, UKBioPhorum, the global organisation accelerating collaboration between biopharmaceutical and medical device industry leaders, is pleased to announce the appointment of Dr. Uwe Buecheler, as Non-Executive Director (NED) to its Board of Directors, effective May 19, 2025.Dr. Buecheler brings a wealth of experience and expertise in the biopharmaceutical industry, having held various leadership roles in development operations, strategic planning, and innovation. He has overseen more than 30 biologics launches, including several top global biopharmaceuticals and has held senior roles in regulatory affairs, CMC development, biosafety, quality, CDMO business and operations.Dr. Buecheler led the expansion of Boehringer Ingelheim's Global Operations Network in the US and China and pioneered the first Biologics MAH approval in Shanghai. He also contributed to major expansion projects in aseptic processing, microbial manufacturing, and large-scale mammalian cell culture operations

European Pharmaceutical Manufacturer
Sep 2nd, 2024
BioPhorum acquires training organisation Brookwood Global

BioPhorum acquires training organisation Brookwood Global.